ESMO Public policy

Influencing EU health policy and informing medical oncologists. 

Public Policy

Public Policy

ESMO’s Public Policy Division supports ESMO members by engaging with EU, global, and national authorities on issues related to the practice and profession of medical oncology.

Policy News

ESMO Endorses WHO Global Strategy Towards Eliminating Cervical Cancer as a Public Health Problem.

View All

Biosimilars portal

Recognition and Status of Medical Oncology

Celebrate ESMO’s 2011 achievement of the recognition of the profession of medical oncology in Europe. Locate national contact points for working across borders, and find answers to FAQs.

EU General Data Protection Regulation

Find out how ESMO supports protecting data privacy as well as the collection and use of patient data for retrospective clinical research, biobanks, and population-based disease registries.

Clinical Trials

Discover how ESMO actively facilitates clinical cancer research, including input into the EU Clinical Trials Regulation, the founding of CAREFOR to safeguard clinical academic cancer research, and ESMO’s offering of research fellowships and clinical trials workshops.

Research

Explore a list of funding organisations, useful links to research groups, research and clinical trials databases, and tools for research projects.

Cancer Prevention

Support ESMO’s efforts to eradicate cancer at its earliest stages through effective cancer prevention awareness.

Big Data and Artificial Intelligence

Keep up to date on ESMO’s efforts to address key issues on how big data and artificial intelligence can provide data to close the gap between medical knowledge and clinical practice.

Workforce Safety

Learn about ESMO’s study to improve working conditions and quality control procedures in order to protect healthcare workers from the adverse effects of occupational exposure to anti-cancer medicines.

Rare Cancers - Europe and Asia

Follow the ESMO-initiated multi-stakeholder partnerships in Europe and Asia that propose solutions to eliminate hurdles faced by rare cancer patients, researchers, medical professionals and the pharmaceutical industry working in this field.

Asia-Pacific Policy Initiatives

With over 24% of ESMO members practicing in Asia-Pacific, ESMO has launched policy activities such as Rare Cancers Asia and will address public policy challenges in the region with data collection, position papers, and educational activities.

World Health Organization / United Nations

Expand your knowledge of global policy issues and ESMO’s collaboration with the World Health Organization to implement the 2017 WHO Cancer Resolution and support countries to achieve the 2030 United Nations goal of Universal Health Coverage.

Tools and Resources

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings